Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Bulk quadrupole contribution to second harmonic generation from classical oscillator model in silicon.

Bauer KD, Hingerl K.

Opt Express. 2017 Oct 30;25(22):26567-26580. doi: 10.1364/OE.25.026567.

PMID:
29092146
2.

Psychosocial variables and obesity-risk-reduction behaviors in Chinese Americans.

Liou D, Bauer KD, Bai Y.

Ecol Food Nutr. 2011 Nov;50(6):486-505. doi: 10.1080/03670244.2011.620877.

PMID:
22077929
3.

Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway.

Handrick R, Ontikatze T, Bauer KD, Freier F, Rübel A, Dürig J, Belka C, Jendrossek V.

Mol Cancer Ther. 2010 Sep;9(9):2497-510. doi: 10.1158/1535-7163.MCT-10-0051. Epub 2010 Jul 27.

4.

Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.

Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Hornéy C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3659-71. Epub 2007 Jul 2.

5.

Exploratory investigation of obesity risk and prevention in Chinese Americans.

Liou D, Bauer KD.

J Nutr Educ Behav. 2007 May-Jun;39(3):134-41.

PMID:
17493563
6.

Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study.

Weaver DL, Krag DN, Manna EA, Ashikaga T, Waters BL, Harlow SP, Bauer KD, Julian TB.

Cancer. 2006 Aug 15;107(4):661-7.

7.

Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

Nallan L, Bauer KD, Bendale P, Rivas K, Yokoyama K, Hornéy CP, Pendyala PR, Floyd D, Lombardo LJ, Williams DK, Hamilton A, Sebti S, Windsor WT, Weber PC, Buckner FS, Chakrabarti D, Gelb MH, Van Voorhis WC.

J Med Chem. 2005 Jun 2;48(11):3704-13.

PMID:
15916422
8.
9.

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD.

Clin Cancer Res. 2002 May;8(5):1085-91.

10.

Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging.

Bauer KD, de la Torre-Bueno J, Diel IJ, Hawes D, Decker WJ, Priddy C, Bossy B, Ludmann S, Yamamoto K, Masih AS, Espinoza FP, Harrington DS.

Clin Cancer Res. 2000 Sep;6(9):3552-9.

11.

Simultaneous measurement of cell cycle and apoptotic cell death.

Moore A, Donahue CJ, Bauer KD, Mather JP.

Methods Cell Biol. 1998;57:265-78. Review.

PMID:
9648110
12.

BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.

Winter JN, Andersen J, Reed JC, Krajewski S, Variakojis D, Bauer KD, Fisher RI, Gordon LI, Oken MM, Jiang S, Jeffries D, Domer P.

Blood. 1998 Feb 15;91(4):1391-8.

PMID:
9454770
13.

Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues.

Moore A, Mercer J, Dutina G, Donahue CJ, Bauer KD, Mather JP, Etcheverry T, Ryll T.

Cytotechnology. 1997 Jan;23(1-3):47-54. doi: 10.1023/A:1007919921991.

14.

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.

Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A.

Curr Biol. 1996 Dec 1;6(12):1669-76.

15.

Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.

Winter JN, Andersen J, Variakojis D, Gordon LI, Fisher RI, Oken MM, Neiman RS, Jiang S, Bauer KD.

Blood. 1996 Nov 15;88(10):3919-25.

PMID:
8916958
16.

Aequorea green fluorescent protein: simultaneous analysis of wild-type and blue-fluorescing mutant by flow cytometry.

Ropp JD, Donahue CJ, Wolfgang-Kimball D, Hooley JJ, Chin JY, Cuthbertson RA, Bauer KD.

Cytometry. 1996 Jul 1;24(3):284-8.

17.

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD, Ashkenazi A.

Curr Biol. 1996 Jun 1;6(6):750-2.

18.

Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.

Schwall RH, Chang LY, Godowski PJ, Kahn DW, Hillan KJ, Bauer KD, Zioncheck TF.

J Cell Biol. 1996 May;133(3):709-18.

20.

Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.

Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX.

Cancer Res. 1996 Mar 15;56(6):1457-65.

21.

Aequorea green fluorescent protein analysis by flow cytometry.

Ropp JD, Donahue CJ, Wolfgang-Kimball D, Hooley JJ, Chin JY, Hoffman RA, Cuthbertson RA, Bauer KD.

Cytometry. 1995 Dec 1;21(4):309-17.

22.

Effects of omeprazole on cell kinetics of carcinogen-induced colon tumours in rats.

Hurwitz A, Sztern MI, Looney GA, Pinson DM, Bauer KD, Kimler BF.

Cell Prolif. 1995 Oct;28(10):525-31.

PMID:
7488672
23.

Apoptosis in CHO cell batch cultures: examination by flow cytometry.

Moore A, Donahue CJ, Hooley J, Stocks DL, Bauer KD, Mather JP.

Cytotechnology. 1995 Feb;17(1):1-11. doi: 10.1007/BF00749215.

PMID:
22359204
24.

Analysis of intracellular proteins.

Bauer KD, Jacobberger JW.

Methods Cell Biol. 1994;41:351-76. Review. No abstract available.

PMID:
7532265
25.

Evidence for molecular heterogeneity in human ganglioneuroblastoma.

Schmidt ML, Salwen HR, Chagnovich D, Bauer KD, Crawford SE, Cohn SL.

Pediatr Pathol. 1993 Nov-Dec;13(6):787-96.

PMID:
8108298
26.

Effect of recombinant aprotinin on platelet activation in patients undergoing open heart surgery.

Matzdorff AC, Green D, Cohen I, Bauer KD.

Haemostasis. 1993 Nov-Dec;23(6):293-300.

PMID:
7518406
27.

DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.

Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR.

Gynecol Oncol. 1993 Jul;50(1):20-4.

PMID:
8349159
28.

Growth factor receptor and related oncogene determination in mesenchymal tumors.

Duda RB, Cundiff D, August CZ, Wagman LD, Bauer KD.

Cancer. 1993 Jun 1;71(11):3526-30.

PMID:
8098266
29.

Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.

Fong CJ, Sutkowski DM, Braun EJ, Bauer KD, Sherwood ER, Lee C, Kozlowski JM.

J Urol. 1993 May;149(5):1190-4.

PMID:
7683344
30.

Fluid-mechanical forces in agitated bioreactors reduce the CD13 and CD33 surface protein content of HL60 cells.

Lakhotia S, Bauer KD, Papoutsakis ET.

Biotechnol Bioeng. 1993 Apr 15;41(9):868-77.

PMID:
18609635
31.

Quality control issues in DNA content flow cytometry.

Bauer KD.

Ann N Y Acad Sci. 1993 Mar 20;677:59-77. Review. No abstract available.

PMID:
8494247
32.
33.

Flow cytometric evaluation of early invasive cervical cancer.

Connor JP, Miller DS, Bauer KD, Murad TM, Rademaker AW, Lurain JR.

Obstet Gynecol. 1993 Mar;81(3):367-71.

PMID:
8437788
34.

Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.

Li BD, Bauer KD, Carney WP, Duda RB.

J Surg Res. 1993 Mar;54(3):179-88.

PMID:
7682635
35.

DNA profile of nephrogenic adenoma assessed by flow cytometry.

Gaylis FD, Keer HN, Bauer KD, Kozlowski JM, Grayhack JT.

Urology. 1993 Feb;41(2):160-1.

PMID:
8497991
36.
37.
38.

Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.

Schenker EL, Hultin LE, Bauer KD, Ferbas J, Margolick JB, Giorgi JV.

Cytometry. 1993;14(3):307-17.

39.
40.

Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer.

Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RJ, Witzig TE, Rabinovitch PS.

Cytometry. 1993;14(5):486-91. Review. No abstract available.

41.

Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology.

Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L, Cox C.

Cytometry. 1993;14(5):472-7. No abstract available. Erratum in: Cytometry 1993 Oct;14(7):842.

42.

Flow cytometric analysis of small renal tumors.

Ellis WJ, Bauer KD, Oyasu R, McVary KT.

J Urol. 1992 Dec;148(6):1774-7.

PMID:
1433605
43.

Damaging agitation intensities increase DNA synthesis rate and alter cell-cycle phase distributions of CHO cells.

Lakhotia S, Bauer KD, Papoutsakis ET.

Biotechnol Bioeng. 1992 Oct 20;40(8):978-90.

PMID:
18601205
44.
45.

Diagnostic utility of DNA content flow cytometry in follicular neoplasms of the thyroid.

Harlow SP, Duda RB, Bauer KD.

J Surg Oncol. 1992 May;50(1):1-6.

PMID:
1573886
47.

Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.

McDunn SH, Winter JN, Variakojis D, Rademaker AW, Von Roenn JH, Tallman MS, Gordon LI, Bauer KD.

J Clin Oncol. 1991 Aug;9(8):1334-40.

PMID:
1677032
48.

Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.

Harlow SP, Eriksen BL, Poggensee L, Chmiel JS, Scarpelli DG, Murad T, Bauer KD.

Cancer Res. 1991 May 1;51(9):2403-9.

49.
50.

Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior.

Keer HN, Gaylis FD, Kozlowski JM, Kwaan HC, Bauer KD, Sinha AA, Wilson MJ.

Prostate. 1991;18(3):201-14.

PMID:
1902292

Supplemental Content

Loading ...
Support Center